[HTML][HTML] PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

N Mu, J Gu, N Liu, X Xue, Z Shu, K Zhang, T Huang… - Theranostics, 2018 - ncbi.nlm.nih.gov
Purpose: Glioblastoma is the most common and aggressive type of primary brain
malignancy and is associated with a poor prognosis. Previously, we found that phosphatase …

PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.

N Mu, J Gu, N Liu, X Xue, Z Shu, K Zhang, T Huang… - Theranostics, 2018 - europepmc.org
Purpose: Glioblastoma is the most common and aggressive type of primary brain
malignancy and is associated with a poor prognosis. Previously, we found that phosphatase …

PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

N Mu, J Gu, N Liu, X Xue, Z Shu, K Zhang… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose: Glioblastoma is the most common and aggressive type of primary brain
malignancy and is associated with a poor prognosis. Previously, we found that phosphatase …

[PDF][PDF] PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

N Mu, J Gu, N Liu, X Xue, Z Shu, K Zhang, T Huang… - researchgate.net
Purpose: Glioblastoma is the most common and aggressive type of primary brain
malignancy and is associated with a poor prognosis. Previously, we found that phosphatase …

[PDF][PDF] PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

N Mu, J Gu, N Liu, X Xue, Z Shu, K Zhang, T Huang… - pdfs.semanticscholar.org
Purpose: Glioblastoma is the most common and aggressive type of primary brain
malignancy and is associated with a poor prognosis. Previously, we found that phosphatase …